Experiences with
Posaconazole10 public posts
Want to take advantage of all our features? Just log in!
or
Antifungals Cut Risk of Invasive Infections in Neutropenic Patients
Posaconazole was also found to be more effective than no prophylaxis/placebo in reducing all-cause mortality. The drug had the highest probability of being the most effective agent in reducing IFI risk and all-cause mortality.